What to tell patients with their first attack of multiple sclerosis

European Neurology

Volumn 36, Issue 4, 1996, Pages 183-190

  Caplan, Louis R ^a   Achiron, A ^b   Houser, Stephen L ^c  

^a TUFTS MEDICAL CENTER   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0029978987     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000117245     Document Type: Article

References (17)

1. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V: MR1 in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligo-clonal banding and CT, Neurology 1988;38: 180-185.
2. Ormerod IEC, Miller DH, McDonald WI, du Boulav EP, Rudge P, Kendall BE, Moseley IF, Johnson G, Tofts PS, Halliday AM, Bronslein AM, Scaravilli F, Harding AE, Barnes D, Zilk-ha KJ: The role of nuclear magnetic resonance imaging in the assessment of multiple sclerosis and isolated neurological lesions, A quantitative study, Brain 1987; 110:1579-1616.
3. vliller DH, McDonald WI, Blumhardt ID, duoulay GH, Halliday AM, Johnson G, Kendall E, Kingsley DPE, MacManus DG, Moseley F, Rudye P, Sandercock PGA: Magnetic reso-îance imaging in isolated spinal cord syn-Jromes, Ann Neurol 1987;22:714-723.
4. Faty DW, Asbury AK, Herndon RM, McFarand HF, McDonald WI, Mcllroy WI, Prineas I Scheinberg LC, Wolinsky JS: Use of mag-ìctic resonance imaging in the diagnosis of nultiple sclerosis, Policy statement, Neurology 1986;36:1575.
5. Mexander L, Berkeley AW, Alexander AM: Prognosis and treatment of multiple sclerosis -3uantitalive nosometric study, JAMA 1958: 166:1943-1949.
6. Lhermitte F, Marteau R, Gazengel J, Dordain 3. Deloche G: The frequency of relapse in mul-iple sclerosis: A study based on 245 cases, J Meurol 1973;205:47-59.
7. Thygescn P: The course of mult iple sclerosis: A close-up of 105 attacks, Copenhagen, Roscn-kilde &Bagger, 1953.
8. Matthews WB: Course and prognosis: in Matthews WB, Compston A, Allen IV, Martyn CN (eds): McAlpinc's Multiple Sclerosis, Edinburgh, Churchill Livingstone, 1991. Pp139-163.
9. Gudmundsson KR: Clinical studies of multiple sclerosis in Iceland, Acta Neurol Scand 1971: 47(suppl 48): 1-78.
10. Bumfield A, Bumfield P: Common psychological problems in multiple sclerosis, BMJ 1978:1: 1193-1194.
11. Dauser S: Multiple sclerosis and other demycli-tating diseases; in Isselbacher KJ, Braunwald 3. Wilson JD, Martin JB, Fauci AS, Kasper DL (eds): Harrison's Principles of Internal Medi-:ine, ed 13. New York, McGraw Hill, 1994. pp 287-2295.
12. joodkin DE: Interferon beta-lb, Lancet 1994; 344:1057-1060.
13. Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupcrsmith MJ, Paty DW, Brown CH, and the Optic Neuritis Study Group: The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis, N Engl J Med 1993:329:1764-1769.
14. McDonald WL, Miller DH, Thompson AJ: Are magnetic resonance findings predictive of clinical outcomes in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta, Ann Neurol 1994:36:14-18.
15. Weinshenkcr BG, Bass B, Rice GPA, Noscworthy J, Carriere W, Baskerville J, Ebers GC: The natural history of multiple sclerosis: A geographically based study, 2. Predictive value of the early course of the disease, Brain 1989; 112: 1419-1428.
16. vlinden SL, Marder WD, Harrold LN, Dor A: vlultiple sclerosis: a Statistical Portrait, New fork, National Multiple Sclerosis Society, 1993.
17. aucr HJ, Hanefcld FA: Multiple sclerosis, Its mpact from childhood to old age, London, iaunders, 1993